Clinical Trial Update: Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports an increase in capillary plexus density following Ozurdex use for diabetic macular edema and related retinal conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy
• Retinal Ischemia

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Retina Macula Specialists of Miami, LLC | Conditions: Diabetic Macular Edema, Diabetic Retinopathy | Phase 4 | Status: UNKNOWN